España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Hologic
HOLX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$70.37
0.64
0.92%
At close: -
$70.37
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Q1 2025 Earnings in 14 days from now on Wed Feb 5th, after the market close
Hologic (HOLX) Forecast
News
Earnings
Hologic (HOLX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Hologic (NASDAQ:HOLX) Stock
Hologic Stock (NASDAQ: HOLX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 17, 2025
FDA Warns Hologic Over BioZorb Manufacturing Violations
Vandana Singh
Monday, January 13, 2025
Morgan Stanley Maintains Equal-Weight on Holo...
Benzinga Newsdesk
Needham Reiterates Buy on Hologic, Maintains ...
Benzinga Newsdesk
Reported Earlies, Hologic Reports Preliminary...
Benzinga Newsdesk
Thursday, December 19, 2024
Needham Reiterates Buy on Hologic, Maintains ...
Benzinga Newsdesk
Wednesday, December 18, 2024
Peering Into Hologic's Recent Short Interest
Benzinga Insights
FDA Announces Implantable Marker Recall: Holo...
Benzinga Newsdesk
Hologic Entered Agreement With The CDC To Dev...
Benzinga Newsdesk
Friday, December 13, 2024
Wolfe Research Initiates Coverage On Hologic ...
Benzinga Newsdesk
Tuesday, December 10, 2024
Hologic Statement On USPSTF Draft Cervical Ca...
Benzinga Newsdesk
This James Hardie Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor
Expert Ratings For Hologic
Benzinga Insights
Jefferies Initiates Coverage On Hologic with ...
Benzinga Newsdesk
Monday, December 02, 2024
Hologic Presented New Research Demonstrating ...
Benzinga Newsdesk
Wednesday, November 27, 2024
Peering Into Hologic's Recent Short Interest
Benzinga Insights
Wednesday, November 06, 2024
Looking Into Hologic's Recent Short Interest
Benzinga Insights
Tuesday, November 05, 2024
Raymond James Maintains Outperform on Hologic...
Benzinga Newsdesk
Mizuho Maintains Outperform on Hologic, Lower...
Benzinga Newsdesk
UBS Maintains Neutral on Hologic, Raises Pric...
Benzinga Newsdesk
RBC Capital Maintains Sector Perform on Holog...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Hologic, Ra...
Benzinga Newsdesk
Hologic shares are trading lower. The company...
Benzinga Newsdesk
Monday, November 04, 2024
Hologic Intends To Enter Into An Accelerated ...
Benzinga Newsdesk
Hologic Sees FY25 Adj. EPS $4.25-$4.35, Reven...
Benzinga Newsdesk
Hologic Q4 2024 Adj. EPS $1.01, Inline, Sales...
Benzinga Newsdesk
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
Piero Cingari
Friday, October 25, 2024
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
Vandana Singh
FDA In Safety Communication Says Do Not Use B...
Benzinga Newsdesk
Tuesday, October 15, 2024
Needham Reiterates Buy on Hologic, Maintains ...
Benzinga Newsdesk
Monday, October 14, 2024
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Vandana Singh
Hologic To Acquire Women's Health Medical Dev...
Benzinga Newsdesk
Tuesday, October 08, 2024
Leerink Partners Maintains Outperform on Holo...
Benzinga Newsdesk
Friday, October 04, 2024
Assessing Hologic: Insights From 10 Financial Analysts
Benzinga Insights
Mizuho Maintains Outperform on Hologic, Raise...
Benzinga Newsdesk
Tuesday, October 01, 2024
Evercore ISI Group Maintains In-Line on Holog...
Benzinga Newsdesk
Citigroup Downgrades Hologic to Neutral, Lowe...
Benzinga Newsdesk
Monday, September 30, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
Benzinga Insights
Friday, September 27, 2024
HOLX Stock Gains From New Offerings Despite Macro Issues
Zacks
Tuesday, September 17, 2024
Critical Insights From Hologic Analyst Ratings: What You Need To Know
Benzinga Insights
Needham Reiterates Buy on Hologic, Maintains ...
Benzinga Newsdesk
Thursday, September 12, 2024
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Benzinga Insights
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Benzinga Insights
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Benzinga Insights
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Benzinga Insights
Monday, September 02, 2024
Peering Into Hologic's Recent Short Interest
Benzinga Insights
Monday, August 19, 2024
Here's How Much You Would Have Made Owning Hologic Stock In The Last 10 Years
Benzinga Insights
Friday, August 16, 2024
Analyst Scoreboard: 8 Ratings For Hologic
Benzinga Insights
RBC Capital Reiterates Sector Perform on Holo...
Benzinga Newsdesk
Tuesday, August 06, 2024
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,200 Today
Benzinga Insights
Thursday, August 01, 2024
Glaukos Q2 Earnings In Line, Glaucoma Drives Sales
Zacks
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch